End-of-day quote
Taiwan S.E.
18:00:00 2024-05-08 EDT
|
5-day change
|
1st Jan Change
|
36.5
TWD
|
+5.04%
|
|
+2.96%
|
+39.31%
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
1,013
|
1,222
|
1,419
|
4,240
|
1,700
|
1,833
|
Enterprise Value (EV)
1 |
1,077
|
1,556
|
1,541
|
4,195
|
1,903
|
1,867
|
P/E ratio
|
25.2
x
|
291
x
|
20.4
x
|
19.5
x
|
16.8
x
|
20.6
x
|
Yield
|
3.6%
|
1.03%
|
3.94%
|
2.93%
|
4.12%
|
3.44%
|
Capitalization / Revenue
|
0.3
x
|
0.44
x
|
0.49
x
|
1.01
x
|
0.46
x
|
0.6
x
|
EV / Revenue
|
0.32
x
|
0.56
x
|
0.54
x
|
1
x
|
0.51
x
|
0.61
x
|
EV / EBITDA
|
10.9
x
|
15.9
x
|
8.2
x
|
12.6
x
|
11.2
x
|
10.1
x
|
EV / FCF
|
4.85
x
|
-367
x
|
5.9
x
|
22.6
x
|
-3.56
x
|
9.54
x
|
FCF Yield
|
20.6%
|
-0.27%
|
16.9%
|
4.42%
|
-28.1%
|
10.5%
|
Price to Book
|
0.84
x
|
1.06
x
|
1.18
x
|
3.1
x
|
1
x
|
1.07
x
|
Nbr of stocks (in thousands)
|
62,899
|
62,654
|
62,079
|
62,079
|
69,943
|
69,943
|
Reference price
2 |
16.11
|
19.50
|
22.85
|
68.30
|
24.30
|
26.20
|
Announcement Date
|
19-04-11
|
20-04-27
|
21-04-26
|
22-03-25
|
23-02-24
|
24-03-01
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
3,383
|
2,762
|
2,866
|
4,204
|
3,721
|
3,059
|
EBITDA
1 |
98.61
|
97.82
|
187.9
|
331.7
|
170
|
184.5
|
EBIT
1 |
27.62
|
23.03
|
109.5
|
248.8
|
96.31
|
119.9
|
Operating Margin
|
0.82%
|
0.83%
|
3.82%
|
5.92%
|
2.59%
|
3.92%
|
Earnings before Tax (EBT)
1 |
53.9
|
24.12
|
112.7
|
266.8
|
142.4
|
126.5
|
Net income
1 |
40.5
|
4.205
|
70.03
|
220.7
|
99.79
|
89.29
|
Net margin
|
1.2%
|
0.15%
|
2.44%
|
5.25%
|
2.68%
|
2.92%
|
EPS
2 |
0.6400
|
0.0670
|
1.120
|
3.510
|
1.450
|
1.270
|
Free Cash Flow
1 |
222.1
|
-4.237
|
261
|
185.6
|
-533.9
|
195.7
|
FCF margin
|
6.56%
|
-0.15%
|
9.11%
|
4.41%
|
-14.35%
|
6.4%
|
FCF Conversion (EBITDA)
|
225.22%
|
-
|
138.88%
|
55.94%
|
-
|
106.09%
|
FCF Conversion (Net income)
|
548.34%
|
-
|
372.74%
|
84.07%
|
-
|
219.22%
|
Dividend per Share
2 |
0.5800
|
0.2000
|
0.9000
|
2.000
|
1.000
|
0.9000
|
Announcement Date
|
19-04-11
|
20-04-27
|
21-04-26
|
22-03-25
|
23-02-24
|
24-03-01
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
63.6
|
334
|
122
|
-
|
203
|
34.9
|
Net Cash position
1 |
-
|
-
|
-
|
44.8
|
-
|
-
|
Leverage (Debt/EBITDA)
|
0.6449
x
|
3.419
x
|
0.6506
x
|
-
|
1.196
x
|
0.1891
x
|
Free Cash Flow
1 |
222
|
-4.24
|
261
|
186
|
-534
|
196
|
ROE (net income / shareholders' equity)
|
3.4%
|
0.36%
|
5.95%
|
17.2%
|
6.5%
|
5.23%
|
ROA (Net income/ Total Assets)
|
0.71%
|
0.61%
|
2.83%
|
6.27%
|
2.21%
|
2.59%
|
Assets
1 |
5,688
|
687.1
|
2,473
|
3,520
|
4,524
|
3,450
|
Book Value Per Share
2 |
19.20
|
18.40
|
19.40
|
22.00
|
24.30
|
24.50
|
Cash Flow per Share
2 |
5.430
|
5.860
|
7.480
|
7.510
|
6.660
|
8.500
|
Capex
1 |
49.4
|
86.1
|
44.6
|
87.3
|
653
|
46.2
|
Capex / Sales
|
1.46%
|
3.12%
|
1.56%
|
2.08%
|
17.54%
|
1.51%
|
Announcement Date
|
19-04-11
|
20-04-27
|
21-04-26
|
22-03-25
|
23-02-24
|
24-03-01
|
|
1st Jan change
|
Capi.
|
---|
| +39.31% | 75.01M | | +17.76% | 66.6B | | +0.84% | 48.75B | | +17.11% | 41.45B | | +22.26% | 26.74B | | +11.45% | 19.55B | | +3.89% | 18.21B | | -21.31% | 16.02B | | +3.82% | 15.62B | | -7.57% | 15.33B |
Other Specialty Chemicals
|